Showing 3831-3840 of 5773 results for "".
- Hanita Lenses Launches Joint Venture with Ophthalmic Vision Care in the Iberian Peninsulahttps://modernod.com/news/hanita-lenses-launches-joint-venture-with-ophthalmic-vision-care-in-the-iberian-peninsula/2480732/Hanita Lenses announced a new joint venture with Madrid, Spain-based Ophthalmic Vision Care (OVC), a distributor IOLs for Hanita Lenses in Spain since 2016. The joint venture, named "Hanita Iberica," merges the assets of OVC—as a service provider of d
- Icare USA Introduces iCare HOME2 Self-Tonometerhttps://modernod.com/news/icare-usa-introduces-icare-home2-self-tonometer/2480731/Icare USA annou
- Ocuphire Meets Endpoints in Phase 3 MIRA-3 Trial Evaluating Nyxol for Reversal of Mydriasishttps://modernod.com/news/ocuphire-announces-positive-topline-results-from-mira-3-phase-3-fda-registration-trial-for-nyxol-in-the-reversal-of-mydriasis/2480730/Ocuphire Pharma announced positive topline results in the MIRA-3 trial, the company’s second phase 3 registration trial investigating its product candidate Nyxol for the reversal of pharmacologically-induced mydriasis (dilation of pupil). Ocuphire announced positive results from i
- FDA Approves Staar Surgical's EVO Visian Implantable Collamer Lenseshttps://modernod.com/news/staar-surgical-announces-fda-approval-of-evo-visian-implantable-collamer-lenses/2480724/Staar Surgical Company announced that the FDA has granted approval of the EVO/EVO+ Visian Implantable Collamer Lens (EVO) for the correction of myopia and myopia with astigmatism. "Following FDA approval, prospective patients in the U.S. and their doctors may n
- Genentech Presents Longer-Term Efficacy and Safety for Enspryng in NMOSDhttps://modernod.com/news/genentech-presents-longer-term-efficacy-and-safety-for-enspryng-in-nmosd/2480720/Genentech is presenting a range of new data from its neuroscience portfolio at the AAN 2022 Annual Meeting (April 2-7 in Seattle), including
- New Multi-Language Options Now Available on Reichert.comhttps://modernod.com/news/new-multi-language-options-now-available-on-reichertcom/2480719/Reichert Technologies, a business unit of Ametek, has announced that Reichert.com is now available in five new language options: Chinese, French, German, Italian, and Spanish. Putting customers first will always be Reichert’s main focus. This new capability will help make the information on
- Haag-Streit Introduces the Imaging Module 910 Slit Lamphttps://modernod.com/news/haag-streit-launhces-the-imaging-module-910-slit-lamp/2480718/Haag-Streit announced the launch of the Imaging Module 910 slit lamp. The device is instantly ready by the turn of a knob and does not require using software. Haag-Streit says capturing images is equally easy—pressing the camera trigger button is all that it takes. "
- Visus Therapeutics Initiates Phase 3 Pivotal Trials of Brimochol PF for the Treatment of Presbyopiahttps://modernod.com/news/visus-therapeutics-initiates-phase-3-pivotal-trials-of-brimochol-pf-for-the-treatment-of-presbyopia/2480710/Visus Therapeutics announced the launch of the first of two pivotal phase 3 trials (BRIO-I and BRIO-II) for its lead asset, Brimochol PF, a preservative-free topical ophthalmic solution for the treatment of presbyopia. The initiation of the BRIO trials follows compelling topline data from th
- Horizon Therapeutics and IAPB Partner to Advocate for Better Eye Healthhttps://modernod.com/news/horizon-therapeutics-and-iapb-partner-to-advocate-for-better-eye-health/2480708/The International Agency for the Prevention of Blindness (IAPB) has announced that Horizon Therapeutics has joined IAPB as a Global Patron. Working together, Horizon and IAPB will advocate to bring better eye health to all at global, country and regional levels. Horizon and IAPB w
- Aerie Pharmaceuticals Appoints Peter Lang as Chief Financial Officerhttps://modernod.com/news/aerie-pharmaceuticals-appoints-peter-lang-as-chief-financial-officer/2480707/Aerie Pharmaceuticals announced that Peter F. Lang will join the company as Chief Financial Officer, effective March 18, 2022. He will report to Raj Kannan, Chief Executive Officer of Aerie Pharmaceuticals, and become a member of the Aerie Executive Committee.